Capstone Partners (IMAP USA) advised Qualanex, LLC, a reverse logistics company supporting the pharmaceutical industry, on its sale to Inmar Intelligence, Inc.

Qualanex, located in Libertyville Illinois, offers customized solutions designed to facilitate and manage the entire return goods process on behalf of pharmaceutical manufacturers and their trading partners. Their comprehensive reverse logistics system includes issuance of return authorization, receipt, processing, data capture, valuation, online reporting, audit verification, sortation, and disposition. The Company employs a team of reverse logistic subject matter experts that possesses many decades of relevant experience and extensive regulatory expertise. They help customers maximize efficiency and leverage behavioral insights via real-time data visibility and reporting.

Inmar Intelligence is a leading data platform company that leverages analytics, AI, machine learning, and integrated workflows to generate insights and help drive innovation at Fortune 500 companies, emerging brands, and health systems. $120B of commerce runs through their market-driven platforms, which are propelling digital transformation through unified data, workflows, and fund flows.

Throughout their 41-year history, they have served retailers, manufacturers, pharmacies, health systems, government offices, and employers as their trusted intermediary in helping them craft digital strategy and redefine success. With the addition of Qualanex, their industry-leading prescription medication returns solutions will help drive increased efficiency and value retention while mitigating risk and minimizing the environmental impact of returns, providing an improved experience for all in the reverse distribution ecosystem.